In this study, we aimed to explore the potential involvement of miR-3150b in hepatocellular carcinoma (HCC) carcinogenesis.
Methods
The expression of miR-3150b and Golgi phosphoprotein 3 (GOLPH3) was determined in HCC cell lines. Cell proliferation, migration and invasion were estimated by Cell Counting Kit-8, wound healing and Transwell assays. The association between miR-3150b and GOLPH3 was verified by luciferase assay.
Results
MiR-3150b was downregulated, while GOLPH3 was remarkably upregulated in HCC cells. Furthermore, miR-3150b inhibited HCC cell proliferation, migration and invasion. MiR-3150b directly targeted and negatively regulated GOLPH3.
Conclusion
MiR-3150b suppressed HCC cell proliferation, invasion and migration by targeting GOLPH3.
LiuY, WangW-M, LuY-F, . Usp5 functions as an oncogene for stimulating tumorigenesis in hepatocellular carcinoma. Oncotarget2017;8:50655.doi:10.18632/oncotarget.16901
2.
SiegelRL, MillerKD, JemalA. Cancer statistics, 2018. CA Cancer J Clin2018;68:7–30.doi:10.3322/caac.21442
3.
AkoadME, PomfretEA. Surgical resection and liver transplantation for hepatocellular carcinoma. Clin Liver Dis2015;19:381–99.doi:10.1016/j.cld.2015.01.007
4.
PronethA, ZemanF, SchlittHJ, . Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis. Ann Surg Oncol2014;21:3096–107.doi:10.1245/s10434-014-3808-1
5.
HansmannJ, RayC. Overview of staging systems for hepatocellular carcinoma and implications for interventional radiology. Semin Intervent Radiol2017;34:213–9.doi:10.1055/s-0037-1602757
6.
FennessyBG, HarneyM, O'SullivanMJ, . Safety, tolerability, and pK of the HDAC inhibitor resminostat in sorafenib-refractory hepatocellular carcinoma (HCC): phase II shelter study. Clin Otolaryngol2012;33.
7.
YangJC-S, WuS-C, RauC-S, . TLR4/NF-κB-responsive microRNAs and their potential target genes: a mouse model of skeletal muscle ischemia-reperfusion injury. Biomed Res Int2015;2015:410721.doi:10.1155/2015/410721
8.
Hao WuZL, ManorLC. Loss of miR-124 and miR-137 expression in glioblastoma multiforme and their roles in glioma cell proliferation and differentiation. Med One2016;1.
9.
HaM, KimVN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol2014;15:509–24.doi:10.1038/nrm3838
10.
CroceCM. 37 causes and consequences of microRNA dysregulation in cancer. Eur J Cancer2012;48:S8–9.doi:10.1016/S0959-8049(12)70741-4
11.
XuC-Z, XieJ, JinB, . Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line. Int J Clin Exp Pathol2013;6:1351–61.
12.
MullanyLE, HerrickJS, WolffRK, . Association of cigarette smoking and microRNA expression in rectal cancer: insight into tumor phenotype. Cancer Epidemiol2016;45:98–107.doi:10.1016/j.canep.2016.10.011
13.
SlatteryML, HerrickJS, MullanyLE, . Diet and lifestyle factors associated with miRNA expression in colorectal tissue. Pharmgenomics Pers Med2017;10:1–16.doi:10.2147/PGPM.S117796
14.
HellerG, AltenbergerC, SteinerI, . Dna methylation of microRNA-coding genes in non-small-cell lung cancer patients. J Pathol2018;245:387–98.doi:10.1002/path.5079
15.
LiT, YouH, MoX, . Golph3 mediated Golgi stress response in modulating N2a cell death upon oxygen-glucose deprivation and reoxygenation injury. Mol Neurobiol2016;53:1377–85.doi:10.1007/s12035-014-9083-0
16.
DaiT, ZhangD, CaiM, . Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway. J Pathol2015;235:490–501.doi:10.1002/path.4479
17.
HuGS, LiYQ, YangYM, . High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma. Tumor Biology2014;35:8625–32.
18.
LiQ, MaY, XuW. High GOLPH3 expression is associated with poor prognosis and invasion of hepatocellular carcinoma. Mol Med Rep2015;11:4315–20.doi:10.3892/mmr.2015.3267
19.
ZengZ, LinH, ZhaoX, . Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FoxO1 transcription factor. Clin Cancer Res2012;18:4059–69.doi:10.1158/1078-0432.CCR-11-3156
20.
ChenF, LiX-F, FuD-S, . Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma. Cancer Biomark2017;18:209–14.doi:10.3233/CBM-161671
21.
GeH, ZouD, WangY, . MicroRNA-377 downregulates Bcl-xL and increases apoptosis in hepatocellular carcinoma cells. oncol res2017;25:29–34.doi:10.3727/096504016X14719078133168
22.
ChangR-M, XiaoS, LeiX, . miRNA-487a promotes proliferation and metastasis in hepatocellular carcinoma. Clin Cancer Res2017;23:2593–604.doi:10.1158/1078-0432.CCR-16-0851
23.
ZhangX, DingZ, MoJ, . Golph3 promotes glioblastoma cell migration and invasion via the mTOR-YB1 pathway in vitro. Mol Carcinog2015;54:1252–63.doi:10.1002/mc.22197
